The Department of Health and Social Care is developing a Medical Technology Strategy to guide how the NHS adopts and integrates new medical devices, digital technologies, and regenerative medicine innovations. The strategy addresses digital transformation challenges, high-cost medical device commissioning, and AI regulation in healthcare, with coordination across NHS England and consideration of international regulatory frameworks.
The government's summary of a proposal for a regulation on simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic devices.
Government response to the recommendations made by the Regulatory Horizons Council (RHC) on the regulation of AI as a medical device.
The government’s plan to build a circular economy for medical technology to increase resilience, drive growth, realise cost savings and improve sustainability.
In response to: Medical technology strategy
Achievements made since the launch of the medtech strategy and the next steps to boost the adoption of medical technology in the NHS.
The government’s plan to support a thriving UK medtech sector and make sure the health and care system can reliably access safe, effective and innovative medical technologies to deliver the best outcomes for patients.
Minister for Science, Research and Innovation and Minister of State for Health and Secondary Care have responded to recommendations made by the Regulatory Horizons Council on the regulation of neurotechnology.
Government’s response to the independent review into racial, ethnic and other factors leading to unfair biases in the design and use of medical devices.
The Department of Health and Social Care's new plan for digital health and social care.
This final version of the strategy sets out ambitious plans to harness the potential of data in health and care in England, while maintaining the highest standards of privacy and ethics.
Outlines what is needed to enable the health and care system to make the best use of technology to support preventative, predictive and personalised care.
We're seeking views from companies producing medical technologies about the sharing of their sales volume data for publication in the Innovation Scorecard.
We're seeking views from companies producing medical technologies about the sharing of their sales volume data for publication in the Innovation Scorecard.
Plans showing how health regulators are ensuring that their approach to regulation supports innovation.